Valsartan Impurity 30 CAS 209911-63-7
| CAS No. | 209911-63-7 |
| Molecular Formula | C14H9Br2N |
| Molecular Weight | 351.04 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Valsartan Impurity 30 is closely related to a nitrogen-containing heterocyclic scaffold, a nitrile group, bromine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
As a process- or degradation-related impurity, Valsartan Impurity 30 (CAS 209911-63-7, C14H9Br2N) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Valsartan Impurity 30 (C14H9Br2N) contains a nitrogen-containing heterocyclic scaffold, a nitrile group, bromine substitution. Halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Valsartan Impurity 30 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C14H9Br2N |
| Molecular Weight | 351.04 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2016 |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 1 |
Related Valsartan Standards
- Valsartan Impurity 103 (CAS 1391068-02-2)
- Valsartan Impurity 128 (CAS CATO-C4X-1057128)
- Valsartan impurity 5 (CAS 676129-92-3)
- Valsartan Impurity 127 (CAS CATO-C4X-1057127)
- Valsartan Impurity 37 (CAS CATO-C4X-105737)
- Valsartan Impurity 62 (CAS 1314799-75-1)
- Valsartan Impurity 20 (CAS CATO-C4X-105720)
- Valsartan Impurity 109 (CAS 2407652-86-0)
Recommended Standards
- 7-Bromo-2-(4-bromophenyl)-1H-indole (CAS 66639-64-3)
- 3-Bromo-5-nitropyridin-4-yl trifluoromethanesulfonate (CAS 1299607-67-2)
- 6-Bromo-2-(4-bromophenyl)-1H-indole (CAS 28718-96-9)
- N'-(4-Chlorobenzylidene)isonicotinohydrazide (CAS 6342-46-7)
- Apixaban Impurity 118 (CAS 2818923-97-4)
- Siponimod Impurity 10 (CAS CATO-C4X-247210)
- Cefcapene Impurity 6 (CAS 86978-24-7)
- N-Nitrosopiperazine (CAS 5632-47-3)
- N4,N4'-Di(naphthalen-2-yl)-[1,1'-biphenyl]-4,4'-diamine (CAS 10311-62-3)
- 1,4-dimethylpyrrolidin-3-amine (CAS 1368129-80-9)
- 2-Bromo-4,5-diethoxybenzoic acid (CAS 708285-67-0)
- 2-Chloro-N-(4-methylphenyl)nicotinamide (CAS 56149-24-7)
- 4-(4-Bromophenyl)oxazole (CAS 54289-73-5)
- Liraglutide Impurity 18 TFA Salt (CAS CATO-C4X-199218)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com